REPORT ID 6191

Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Report 2017

Publish Date
25-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the global Peripheral Arterial Disease (PAD) Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Peripheral Arterial Disease (PAD) Therapeutics for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Peripheral Arterial Disease (PAD) Therapeutics market competition by top manufacturers/players, with Peripheral Arterial Disease (PAD) Therapeutics sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca Plc. (UK)
    Bayer HealthCare Pharmaceuticals (Germany)
    Bristol-Myers Squibb Company (US)
    Merck & Co., Inc. (US)
    Proteon Therapeutics, Inc. (US)
    Sanofi S.A. (France)
    Symic Bio, Inc. (US)
    TheraVasc Inc. (US)
    AnGes MG, Inc. (Japan)
    Athersys, Inc. (US)
    Betagenon AB (Sweden)
    miRagen Therapeutics, Inc. (US)
    Multi Gene Vascular Systems Ltd (Israel)
    ViroMed Co. Ltd. (Korea)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Anti-Platelet Drugs
    Dual Antiplatelet Therapy Drugs
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Report 2017
1 Peripheral Arterial Disease (PAD) Therapeutics Market Overview
    1.1 Product Overview and Scope of Peripheral Arterial Disease (PAD) Therapeutics
    1.2 Classification of Peripheral Arterial Disease (PAD) Therapeutics by Product Category
        1.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Anti-Platelet Drugs
        1.2.4 Dual Antiplatelet Therapy Drugs
        1.2.5 Others
    1.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market by Application/End Users
        1.3.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Peripheral Arterial Disease (PAD) Therapeutics Market by Region
        1.4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
        1.4.3 China Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
        1.4.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
        1.4.5 Japan Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
        1.4.7 India Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Peripheral Arterial Disease (PAD) Therapeutics (2012-2022)
        1.5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2012-2022)

2 Global Peripheral Arterial Disease (PAD) Therapeutics Competition by Players/Suppliers, Type and Application
     2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Competition by Players/Suppliers
        2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Peripheral Arterial Disease (PAD) Therapeutics (Volume and Value) by Type
        2.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Type (2012-2017)
        2.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue and Market Share by Type (2012-2017)
    2.3 Global Peripheral Arterial Disease (PAD) Therapeutics (Volume and Value) by Region
        2.3.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Region (2012-2017)
        2.3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue and Market Share by Region (2012-2017)
    2.4 Global Peripheral Arterial Disease (PAD) Therapeutics (Volume) by Application

3 United States Peripheral Arterial Disease (PAD) Therapeutics (Volume, Value and Sales Price)
    3.1 United States Peripheral Arterial Disease (PAD) Therapeutics Sales and Value (2012-2017)
        3.1.1 United States Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2012-2017)
        3.1.2 United States Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2012-2017)
        3.1.3 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Price Trend (2012-2017)
    3.2 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Players
    3.3 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Type
    3.4 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Application

4 China Peripheral Arterial Disease (PAD) Therapeutics (Volume, Value and Sales Price)
    4.1 China Peripheral Arterial Disease (PAD) Therapeutics Sales and Value (2012-2017)
        4.1.1 China Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2012-2017)
        4.1.2 China Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2012-2017)
        4.1.3 China Peripheral Arterial Disease (PAD) Therapeutics Sales Price Trend (2012-2017)
    4.2 China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Players
    4.3 China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Type
    4.4 China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Application

5 Europe Peripheral Arterial Disease (PAD) Therapeutics (Volume, Value and Sales Price)
    5.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Value (2012-2017)
        5.1.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2012-2017)
        5.1.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Price Trend (2012-2017)
    5.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Players
    5.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Type
    5.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Application

6 Japan Peripheral Arterial Disease (PAD) Therapeutics (Volume, Value and Sales Price)
    6.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Sales and Value (2012-2017)
        6.1.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2012-2017)
        6.1.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Peripheral Arterial Disease (PAD) Therapeutics Sales Price Trend (2012-2017)
    6.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Players
    6.3 Japan Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Type
    6.4 Japan Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Application

7 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics (Volume, Value and Sales Price)
    7.1 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales and Value (2012-2017)
        7.1.1 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales Price Trend (2012-2017)
    7.2 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Players
    7.3 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Type
    7.4 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Application

8 India Peripheral Arterial Disease (PAD) Therapeutics (Volume, Value and Sales Price)
    8.1 India Peripheral Arterial Disease (PAD) Therapeutics Sales and Value (2012-2017)
        8.1.1 India Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2012-2017)
        8.1.2 India Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2012-2017)
        8.1.3 India Peripheral Arterial Disease (PAD) Therapeutics Sales Price Trend (2012-2017)
    8.2 India Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Players
    8.3 India Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Type
    8.4 India Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share by Application

9 Global Peripheral Arterial Disease (PAD) Therapeutics Players/Suppliers Profiles and Sales Data
    9.1 AstraZeneca Plc. (UK)
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Bayer HealthCare Pharmaceuticals (Germany)
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Bristol-Myers Squibb Company (US)
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Merck & Co., Inc. (US)
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Proteon Therapeutics, Inc. (US)
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Sanofi S.A. (France)
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Symic Bio, Inc. (US)
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 TheraVasc Inc. (US)
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 AnGes MG, Inc. (Japan)
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Athersys, Inc. (US)
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Betagenon AB (Sweden)
    9.12 miRagen Therapeutics, Inc. (US)
    9.13 Multi Gene Vascular Systems Ltd (Israel)
    9.14 ViroMed Co. Ltd. (Korea)

10 Peripheral Arterial Disease (PAD) Therapeutics Maufacturing Cost Analysis
    10.1 Peripheral Arterial Disease (PAD) Therapeutics Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Therapeutics
    10.3 Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Therapeutics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Peripheral Arterial Disease (PAD) Therapeutics Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast (2017-2022)
    14.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Volume, Revenue and Pr